Our results revealed that patients with BMI > 25 kg/m2 had higher concentrations of serum levels of resistin, chemerin and visfatin, insulin resistance-markers and serum levels of inflammatory cytokines, compared with patients with BMI > 25 kg/m2. The gene discussed is NAMPT; the disease is Insulin resistance.